Authors: Kijak, GH Pampuro, SE Avila, MM Zala, C Cahn, P Wainberg, MA Salomon, H

Citation: Gh. Kijak et al., Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina, ANTIVIR TH, 6(1), 2001, pp. 71-77

Authors: Zala, C Rouleau, D Montaner, JSG

Citation: C. Zala et al., Role of hydroxyurea in treatment of disease due to human immunodeficiency virus infection, CLIN INF D, 30, 2000, pp. S143-S150

Authors: Zala, C Ochoa, C Krolewiecki, A Patterson, P Cahn, P Crawford, RI Montaner, JSG

Citation: C. Zala et al., Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals, AIDS, 14(14), 2000, pp. 2217-2218

Authors: Montaner, JSG Mo, T Raboud, JM Rae, S Alexander, CS Zala, C Rouleau, D Harrigan, PR

Citation: Jsg. Montaner et al., Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine, J INFEC DIS, 181(2), 2000, pp. 729-732

Authors: Zala, C Salomon, H Cahn, P

Citation: C. Zala et al., Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea, ANTIVIR TH, 4, 1999, pp. 95-99

Authors: Forrest, DM Zala, C Djurdjev, O Singer, J Craib, KJP Lawson, L Russell, JA Montaner, JSG

Citation: Dm. Forrest et al., Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia, ARCH IN MED, 159(7), 1999, pp. 741-747